Many triple-negative breast cancers, characterized by the absence of ERα, progesterone receptor (PR) and human epidermal growth factor receptor 2 (Her2), also possess ERβ and an androgen receptor (AR) [49]. The gene discussed is PGR; the disease is triple-negative breast carcinoma.